The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-Hydroxy-3-(pyrrolidin-1-yl)propyl)-6-o-tolyl-1H-pyrazolo-[3,4-b]pyridine-4-carboxamide ID: ALA4743519
PubChem CID: 162646627
Max Phase: Preclinical
Molecular Formula: C21H25N5O2
Molecular Weight: 379.46
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccccc1-c1cc(C(=O)NCC(O)CN2CCCC2)c2cn[nH]c2n1
Standard InChI: InChI=1S/C21H25N5O2/c1-14-6-2-3-7-16(14)19-10-17(18-12-23-25-20(18)24-19)21(28)22-11-15(27)13-26-8-4-5-9-26/h2-3,6-7,10,12,15,27H,4-5,8-9,11,13H2,1H3,(H,22,28)(H,23,24,25)
Standard InChI Key: OBYYAVWJEDVZFK-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
15.7192 -12.4890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7181 -13.3085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4261 -13.7175 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.4243 -12.0801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0119 -13.7168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3042 -13.3059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5967 -13.7133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5956 -14.5314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3080 -14.9404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0126 -14.5307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3057 -12.4888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4219 -11.2629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1284 -10.8522 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.7129 -10.8564 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.1329 -12.4854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1332 -13.3040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9118 -13.5567 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.3929 -12.8943 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9114 -12.2322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1259 -10.0350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8324 -9.6243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8300 -8.8071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5364 -8.3964 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.2836 -8.7244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8286 -8.1155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4178 -7.4090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6191 -7.5814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5413 -10.0308 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 16 2 0
15 4 2 0
4 1 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
2 5 1 0
6 11 1 0
4 12 1 0
12 13 1 0
12 14 2 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 15 1 0
13 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 23 1 0
21 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 379.46Molecular Weight (Monoisotopic): 379.2008AlogP: 2.12#Rotatable Bonds: 6Polar Surface Area: 94.14Molecular Species: BASEHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.96CX Basic pKa: 8.80CX LogP: 1.59CX LogD: 0.42Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.61Np Likeness Score: -1.69
References 1. Cowen SD,Russell D,Dakin LA,Chen H,Larsen NA,Godin R,Throner S,Zheng X,Molina A,Wu J,Cheung T,Howard T,Garcia-Arenas R,Keen N,Pendleton CS,Pietenpol JA,Ferguson AD. (2016) Design, Synthesis, and Biological Activity of Substrate Competitive SMYD2 Inhibitors., 59 (24): [PMID:28002961 ] [10.1021/acs.jmedchem.6b01303 ]